Immunoconjugate modules. Immunoconjugates are composed of three different components: a monoclonal antibody, a therapeutic entity, and a linker that joins the antibody and the therapeutic agent. Using this basic immunoconjugate model, different therapeutic entities, including pharmacologics, radioactive agents, and toxins, can be delivered to the cancer cells.